ZA973836B - Pharmaceutical composition based on stabilized lipophilic matrices for the controlled release of active principles. - Google Patents

Pharmaceutical composition based on stabilized lipophilic matrices for the controlled release of active principles.

Info

Publication number: ZA973836B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical composition; controlled release; composition based; active principles; lipophilic matrices
Prior art date: 1996-05-06

Application number

ZA9703836A

Other languages

English (en)

Inventor

Gilles Fonknechten

Patrick Genty

Original Assignee

Adir

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-06

Filing date

1997-05-05

Publication date

1997-12-02

1997-05-05 Application filed by Adir filed Critical Adir

1997-12-02 Publication of ZA973836B publication Critical patent/ZA973836B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Obesity (AREA)
Hematology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Child & Adolescent Psychology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

ZA9703836A 1996-05-06 1997-05-05 Pharmaceutical composition based on stabilized lipophilic matrices for the controlled release of active principles. ZA973836B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9605606A FR2748209B1 (fr)	1996-05-06	1996-05-06	Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs

Publications (1)

Publication Number	Publication Date
ZA973836B true ZA973836B (en)	1997-12-02

Family

ID=9491845

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9703836A ZA973836B (en)	1996-05-06	1997-05-05	Pharmaceutical composition based on stabilized lipophilic matrices for the controlled release of active principles.

Country Status (16)

Country	Link
EP (1)	EP0806202B1 (hu)
JP (1)	JP3983339B2 (hu)
CN (1)	CN1171270A (hu)
AT (1)	ATE212543T1 (hu)
AU (1)	AU720146B2 (hu)
CA (1)	CA2204475C (hu)
DE (1)	DE69710121T2 (hu)
DK (1)	DK0806202T3 (hu)
ES (1)	ES2170922T3 (hu)
FR (1)	FR2748209B1 (hu)
HU (1)	HU222045B1 (hu)
NO (1)	NO318227B1 (hu)
NZ (1)	NZ314740A (hu)
PL (1)	PL190562B1 (hu)
PT (1)	PT806202E (hu)
ZA (1)	ZA973836B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE1011363A3 (fr) *	1997-09-11	1999-08-03	Smb Technology	Capsules semi-solides autoemulsionnables matricielles a action prolongee.
FR2782006B1 (fr) *	1998-08-07	2002-04-19	Gattefosse Ets Sa	Composition a liberation prolongee apte a former une micro-emulsion
DE10161078A1 (de) *	2001-12-12	2003-08-28	Achim Goepferich	Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen
WO2004006889A1 (en) *	2002-07-15	2004-01-22	Alcon, Inc.	Bioerodible film for ophthalmic drug delivery
CN102552917A (zh)	2003-08-13	2012-07-11	比奥孔有限公司	用于治疗剂的微-粒子脂肪酸盐固体剂量制剂
GB0324574D0 (en) *	2003-10-21	2003-11-26	Glaxo Group Ltd	Novel compositions
WO2007050724A2 (en) *	2005-10-26	2007-05-03	Banner Pharmacaps, Inc.	Lipophilic vehicle-based dual controlled release matrix system as capsule fill
EP1959935A2 (en)	2005-10-26	2008-08-27	Banner Pharmacaps Inc.	Hydrophilic vehicle-based dual controlled release matrix system as capsule fill
US8198268B2 (en)	2008-10-31	2012-06-12	Janssen Biotech, Inc.	Tianeptine sulfate salt forms and methods of making and using the same
JP2013119540A (ja) *	2011-12-08	2013-06-17	Nipro Corp	固形医薬組成物およびその製造法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4797286A (en) *	1985-11-12	1989-01-10	Eli Lilly And Company	Orally administerable sustained release pharmaceutical formulations
DE4413350A1 (de) *	1994-04-18	1995-10-19	Basf Ag	Retard-Matrixpellets und Verfahren zu ihrer Herstellung
US5545628A (en) *	1995-01-10	1996-08-13	Galephar P.R. Inc.	Pharmaceutical composition containing fenofibrate

1996
- 1996-05-06 FR FR9605606A patent/FR2748209B1/fr not_active Expired - Fee Related
1997
- 1997-05-02 DE DE69710121T patent/DE69710121T2/de not_active Expired - Lifetime
- 1997-05-02 AT AT97400990T patent/ATE212543T1/de active
- 1997-05-02 EP EP97400990A patent/EP0806202B1/fr not_active Expired - Lifetime
- 1997-05-02 DK DK97400990T patent/DK0806202T3/da active
- 1997-05-02 ES ES97400990T patent/ES2170922T3/es not_active Expired - Lifetime
- 1997-05-02 PT PT97400990T patent/PT806202E/pt unknown
- 1997-05-05 HU HU9700842A patent/HU222045B1/hu not_active IP Right Cessation
- 1997-05-05 AU AU19991/97A patent/AU720146B2/en not_active Ceased
- 1997-05-05 CN CN97109780A patent/CN1171270A/zh active Pending
- 1997-05-05 PL PL97319808A patent/PL190562B1/pl not_active IP Right Cessation
- 1997-05-05 ZA ZA9703836A patent/ZA973836B/xx unknown
- 1997-05-05 CA CA002204475A patent/CA2204475C/fr not_active Expired - Fee Related
- 1997-05-05 NZ NZ314740A patent/NZ314740A/en not_active IP Right Cessation
- 1997-05-05 NO NO19972068A patent/NO318227B1/no not_active IP Right Cessation
- 1997-05-06 JP JP11554897A patent/JP3983339B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0806202A1 (fr)	1997-11-12
NO318227B1 (no)	2005-02-21
JPH1045629A (ja)	1998-02-17
NZ314740A (en)	1998-11-25
CN1171270A (zh)	1998-01-28
NO972068D0 (no)	1997-05-05
JP3983339B2 (ja)	2007-09-26
PT806202E (pt)	2002-06-28
DK0806202T3 (da)	2002-05-06
HU9700842D0 (en)	1997-06-30
HU222045B1 (hu)	2003-04-28
DE69710121T2 (de)	2002-11-28
FR2748209B1 (fr)	1998-06-05
DE69710121D1 (de)	2002-03-14
AU720146B2 (en)	2000-05-25
PL319808A1 (en)	1997-11-10
FR2748209A1 (fr)	1997-11-07
EP0806202B1 (fr)	2002-01-30
PL190562B1 (pl)	2005-12-30
NO972068L (no)	1997-11-07
AU1999197A (en)	1997-11-13
CA2204475C (fr)	2002-12-03
CA2204475A1 (fr)	1997-11-06
ATE212543T1 (de)	2002-02-15
ES2170922T3 (es)	2002-08-16
HUP9700842A1 (hu)	1998-08-28

Similar Documents

Publication	Publication Date	Title
EP0350246A3 (en)	1990-03-28	Sustained release microcapsule for water soluble drug
GR3035308T3 (en)	2001-04-30	Bioadhesive pharmaceutical composition for controlled release of drugs.
EP1132104A3 (de)	2002-03-20	Spender für Medien
AU3418993A (en)	1993-07-28	System for delivering an active substance for sustained release
HU9300768D0 (en)	1993-06-28	Veramply tablet of controlled dissolution
AU651894B2 (en)	1994-08-04	Matrix tablet permitting the sustained release of indapamide after oral administration
CA2134885A1 (en)	1993-12-09	Reduced odor fragrance sampler
HU0301253D0 (en)	2003-07-28	Active ingredient containing plaster
ZA894020B (en)	1990-02-28	Controlled release pharmaceutical formulation
ZA973836B (en)	1997-12-02	Pharmaceutical composition based on stabilized lipophilic matrices for the controlled release of active principles.
HU902253D0 (en)	1990-08-28	Insecticide preparatives containing phenyl-substituted heterocyclic compounds as active substance and process for producing the active substances
HUP0100024A3 (en)	2002-12-28	Pharmaceutical compositions for treating alzheimer's disease containing carvedilol as active ingredient
GB2226804B (en)	1992-09-02	Process for preparing microcapsules providing the rapid release of a drug as active ingredient
CA2294448A1 (en)	1998-12-30	Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins
AU3318389A (en)	1989-10-26	Azelastine-containing medicaments with controlled release of the active substance
CA2350659A1 (en)	2000-05-25	Pharmaceutical composition for modified release insulin sensitiser
HUT75029A (en)	1997-03-28	Systems for controlled release of pilocarpine, and semipermeable capsule containing the active ingredient
ZA938848B (en)	1995-04-06	Stabilised superoxide dismutase (SOD) composition.
IL89521A0 (en)	1989-09-10	Controlled release system for orally administered active substances
HUT50787A (en)	1990-03-28	Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
CS240991A3 (en)	1992-03-18	Solid forms for oral administration, said forms containing iphosphamide as active component
ATE80797T1 (de)	1992-10-15	Hemizellulosematrix enthaltende arzneizubereitungen mit verzoegerter freisetzung.
GB9302004D0 (en)	1993-03-17	A device for protacted release of active substances,perfumes and similar volatile substances
AU656199B2 (en)	1995-01-27	A pharmaceutical preparation containing a thrombolytically active substance
HUT47205A (en)	1989-02-28	Stabilized solid insecticides containing as active substance s,s'-(2)dimethyl-amin(-trimethilen-)bis-(benzosulphonate)